142 related articles for article (PubMed ID: 20572024)
1. Fluoxetine and infantile hypertrophic pylorus stenosis: a signal from a birth defects-drug exposure surveillance study.
Bakker MK; De Walle HE; Wilffert B; de Jong-Van den Berg LT
Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):808-13. PubMed ID: 20572024
[TBL] [Abstract][Full Text] [Related]
2. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
Diav-Citrin O; Shechtman S; Weinbaum D; Wajnberg R; Avgil M; Di Gianantonio E; Clementi M; Weber-Schoendorfer C; Schaefer C; Ornoy A
Br J Clin Pharmacol; 2008 Nov; 66(5):695-705. PubMed ID: 18754846
[TBL] [Abstract][Full Text] [Related]
3. The incidence of infantile hypertrophic pyloric stenosis and its association with folic acid supplementation during pregnancy: A nested case-control study.
Rosenthal YS; Chodick G; Grossman Z; Shalev V; Koren G
J Pediatr Surg; 2019 Apr; 54(4):701-706. PubMed ID: 29884554
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and descriptive epidemiology of infantile hypertrophic pyloric stenosis in the United States: A multistate, population-based retrospective study, 1999-2010.
Kapoor R; Kancherla V; Cao Y; Oleson J; Suhl J; Canfield MA; Druschel CM; Kirby RS; Meyer RE; Romitti PA
Birth Defects Res; 2019 Feb; 111(3):159-169. PubMed ID: 30549250
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine in early pregnancy: cardiac birth defects.
Prescrire Int; 2011 Jun; 20(117):155. PubMed ID: 21678707
[No Abstract] [Full Text] [Related]
6. The fetal safety of fluoxetine: a systematic review and meta-analysis.
Riggin L; Frankel Z; Moretti M; Pupco A; Koren G
J Obstet Gynaecol Can; 2013 Apr; 35(4):362-369. PubMed ID: 23660045
[TBL] [Abstract][Full Text] [Related]
7. Effects of first-trimester fluoxetine exposure on the newborn.
Goldstein DJ; Corbin LA; Sundell KL
Obstet Gynecol; 1997 May; 89(5 Pt 1):713-8. PubMed ID: 9166307
[TBL] [Abstract][Full Text] [Related]
8. Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study.
Lund M; Pasternak B; Davidsen RB; Feenstra B; Krogh C; Diaz LJ; Wohlfahrt J; Melbye M
BMJ; 2014 Mar; 348():g1908. PubMed ID: 24618148
[TBL] [Abstract][Full Text] [Related]
9. Maternal and pregnancy characteristics and risk of infantile hypertrophic pyloric stenosis.
Svenningsson A; Svensson T; Akre O; Nordenskjöld A
J Pediatr Surg; 2014 Aug; 49(8):1226-31. PubMed ID: 25092081
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin reuptake inhibitors and risk for major congenital anomalies.
Malm H; Artama M; Gissler M; Ritvanen A
Obstet Gynecol; 2011 Jul; 118(1):111-120. PubMed ID: 21646927
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.
Wemakor A; Casson K; Garne E; Bakker M; Addor MC; Arriola L; Gatt M; Khoshnood B; Klungsoyr K; Nelen V; O'Mahoney M; Pierini A; Rissmann A; Tucker D; Boyle B; de Jong-van den Berg L; Dolk H
Eur J Epidemiol; 2015 Nov; 30(11):1187-98. PubMed ID: 26148560
[TBL] [Abstract][Full Text] [Related]
12. Birth outcomes in pregnant women taking fluoxetine.
Johnson GL
J Fam Pract; 1997 Jan; 44(1):32. PubMed ID: 9010368
[No Abstract] [Full Text] [Related]
13. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
Louik C; Lin AE; Werler MM; Hernández-Díaz S; Mitchell AA
N Engl J Med; 2007 Jun; 356(26):2675-83. PubMed ID: 17596601
[TBL] [Abstract][Full Text] [Related]
14. Maternal factors in the origin of infantile hypertrophic pyloric stenosis: A population-based case-control study.
Vermes G; László D; Czeizel AE; Ács N
Congenit Anom (Kyoto); 2016 Mar; 56(2):65-72. PubMed ID: 26394719
[TBL] [Abstract][Full Text] [Related]
15. Birth outcomes in pregnant women taking fluoxetine.
Chambers CD; Johnson KA; Dick LM; Felix RJ; Jones KL
N Engl J Med; 1996 Oct; 335(14):1010-5. PubMed ID: 8793924
[TBL] [Abstract][Full Text] [Related]
16. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.
Alwan S; Reefhuis J; Rasmussen SA; Olney RS; Friedman JM;
N Engl J Med; 2007 Jun; 356(26):2684-92. PubMed ID: 17596602
[TBL] [Abstract][Full Text] [Related]
17. Sertraline use during pregnancy and the risk of major malformations.
Bérard A; Zhao JP; Sheehy O
Am J Obstet Gynecol; 2015 Jun; 212(6):795.e1-795.e12. PubMed ID: 25637841
[TBL] [Abstract][Full Text] [Related]
18. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
Prescrire Int; 1999 Oct; 8(43):157-9. PubMed ID: 11503843
[TBL] [Abstract][Full Text] [Related]
19. Similarities and differences in the epidemiology of pyloric stenosis and SIDS.
Lisonkova S; Joseph KS
Matern Child Health J; 2014 Sep; 18(7):1721-7. PubMed ID: 24337864
[TBL] [Abstract][Full Text] [Related]
20. Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring.
Sujan AC; Rickert ME; Öberg AS; Quinn PD; Hernández-Díaz S; Almqvist C; Lichtenstein P; Larsson H; D'Onofrio BM
JAMA; 2017 Apr; 317(15):1553-1562. PubMed ID: 28418479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
